Inhibikase Therapeutics, INC. (IKT) SEC Filings — 2024
32 SEC filings for Inhibikase Therapeutics, INC. (IKT) in 2024.
Filings
- Inhibikase Therapeutics Terminates Material Agreement — 8-K · Dec 5, 2024
- Inhibikase Therapeutics Files 2025 Proxy Statement — DEF 14A · Nov 18, 2024
- Inhibikase Therapeutics, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Inhibikase Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Inhibikase Therapeutics, INC. SC 13G Filing — SC 13G · Oct 28, 2024
- Inhibikase Therapeutics, INC. SC 13G Filing — SC 13G · Oct 28, 2024
- Inhibikase Therapeutics, INC. SC 13G Filing — SC 13G · Oct 25, 2024
- Inhibikase Therapeutics Files 8-K on Agreements and Personnel Changes — 8-K · Oct 22, 2024
- Inhibikase Therapeutics, INC. SC 13G Filing — SC 13G · Oct 17, 2024
- Inhibikase Therapeutics, INC. SC 13G Filing — SC 13G · Oct 17, 2024
- Inhibikase Therapeutics Announces CMO Departure, Interim Appointment — 8-K · Oct 10, 2024
- Inhibikase Therapeutics, INC. SC 13G Filing — SC 13G · Oct 10, 2024
- Inhibikase Therapeutics Files 8-K — 8-K · Oct 9, 2024
- Inhibikase Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- Inhibikase Therapeutics Files 8-K on Shareholder Votes — 8-K · Aug 6, 2024
- Inhibikase Therapeutics Files Additional Proxy Materials — DEFA14A · Jun 21, 2024
- Inhibikase Therapeutics Files Definitive Proxy Statement — DEF 14A · Jun 20, 2024
- Inhibikase Therapeutics Files S-1 Registration — S-1 · Jun 18, 2024
- Inhibikase Therapeutics Reports on Shareholder Vote Matters — 8-K · Jun 10, 2024
- Inhibikase Therapeutics Files 8-K with Material Agreements — 8-K · May 20, 2024
- Inhibikase Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Inhibikase Therapeutics Files Amendment to S-1 Registration Statement — S-1/A · May 9, 2024
- Inhibikase Therapeutics Files 8-K — 8-K · Apr 30, 2024
- Inhibikase Therapeutics Files S-1/A Amendment — S-1/A · Apr 29, 2024
- Inhibikase Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- Inhibikase Therapeutics Files Amendment to S-1 Registration Statement — S-1/A · Apr 25, 2024
- Inhibikase Therapeutics Files S-1 Registration Statement — S-1 · Apr 19, 2024
- Inhibikase Therapeutics Files 8-K/A Amendment — 8-K/A · Apr 2, 2024
- Inhibikase Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 27, 2024
- Inhibikase Therapeutics Files 8-K for 'Other Events' — 8-K · Feb 7, 2024
- Inhibikase Therapeutics Reports Material Definitive Agreement — 8-K · Feb 1, 2024
- Inhibikase Therapeutics 8-K: Executive Comp & Officer Changes — 8-K · Jan 16, 2024